TOCILIZUMAB: RoActemra(UK) ACTEMRA (ROCHE) aproved in UK for Juvenile RA.

ROCHE RoACTEMRA approved in UK for Juvenile RA. 

ROCHE multi-country ACTEMRA trial on Ankylosing Spondylitis not yet published.

DRUG cost of 400mg MONTHLY sub.cut infusion $1700. (4-8mg/kg).

UK IMPERIAL COLLEGE,LONDON. BIOMEDICAL ENGINEERING

SEE COMMENT FOR DETAILS